Shiho Ofuchi

Title: Shiho Ofuchi: Innovator in KLK5 Inhibitory Peptide Research

Introduction

Shiho Ofuchi is a prominent inventor based in Shinagawa-ku, Japan. She has made significant contributions to the field of biotechnology, particularly in the development of KLK5 inhibitory peptide conjugates. With a total of 2 patents, her work is paving the way for new therapeutic options.

Latest Patents

Ofuchi's latest patents focus on KLK5 inhibitory peptide - SPINK2 mutant peptide conjugates. These conjugates are designed to inhibit KLK5, a serine protease implicated in various diseases. The conjugates are Fc fusion peptides, where the Fc region is derived from human IgG1 or its fragments. The amino acid sequences of these conjugates include specific sequences identified as SEQ ID NOs: 34, 36, 38, 40, 42, 44, 46, 48, 96, 50, 52, 54, 56, 58, or 60. Additionally, pharmaceutical compositions containing these conjugates are being developed for treating KLK5-related diseases.

Career Highlights

Shiho Ofuchi is currently employed at Daiichi Sankyo Company, Limited, where she continues her innovative research. Her work has garnered attention in the scientific community, contributing to advancements in therapeutic strategies.

Collaborations

Ofuchi collaborates with notable colleagues, including Daisuke Nishimiya and Hidenori Yano. These partnerships enhance the research efforts and broaden the impact of their findings in the field.

Conclusion

Shiho Ofuchi's contributions to KLK5 inhibitory peptide research exemplify her dedication to innovation in biotechnology. Her patents and ongoing work at Daiichi Sankyo Company, Limited, highlight her role as a leading inventor in this important area of study.